Cytosine-Guanine-rich DNA minor groove (CG-rich DNA minor groove) (CG-rich DNA minor groove)

The Cytosine-Guanine-rich (CG-rich) DNA minor groove is a specific structural domain within the DNA double helix characterized by a high density of guanine and cytosine base pairs. This region is biologically critical as it serves as the primary binding site for various regulatory proteins, most notably the Sp1 (Specificity Protein 1) family of transcription factors, which control the expression of genes involved in cell growth, survival, and angiogenesis (Source: PubMed, PMID: 21530143). Therapeutic agents such as the aureolic acid antibiotic Mithramycin A (Plicamycin) target this groove by binding with high affinity to GC-rich sequences, thereby displacing transcription factors and inhibiting the transcription of oncogenes (Source: NIH, PubChem CID 16219656). This mechanism of action makes the CG-rich minor groove a significant target in the treatment of certain cancers and Paget's disease of bone. However, drugs targeting this site often face challenges related to systemic toxicity, including severe hepatotoxicity and thrombocytopenia, due to their relative lack of sequence specificity across the genome (Source: StatPearls, NBK559050). Modern drug development efforts include the design of synthetic polyamides that can be programmed to recognize specific DNA sequences within the minor groove to improve therapeutic precision. Understanding the structural nuances of the CG-rich minor groove remains vital for the advancement of DNA-targeted chemotherapy.

Other names

GC-rich DNA minor grooveGuanine-Cytosine rich DNA minor grooveDNA minor groove (GC-rich)

Small molecules bind non-covalently within the minor groove of DNA at sequences rich in cytosine and guanine, displacing transcription factors and inhibiting gene expression (Source: PubMed, PMID: 21530143).